tiprankstipranks
Eagle Pharmaceuticals says in default under credit agreement
PremiumThe FlyEagle Pharmaceuticals says in default under credit agreement
2M ago
Eagle Pharmaceuticals delays annual report on Form 10-K filing
Premium
The Fly
Eagle Pharmaceuticals delays annual report on Form 10-K filing
2M ago
Eagle Pharmaceuticals commences review to evaluate range of alternatives
Premium
The Fly
Eagle Pharmaceuticals commences review to evaluate range of alternatives
2M ago
Eagle Pharmaceuticals says unlikely to file Form 10-Q or 10-K by May 13
PremiumThe FlyEagle Pharmaceuticals says unlikely to file Form 10-Q or 10-K by May 13
7M ago
Eagle Pharmaceuticals to present data from Phase III trial of amisulpride
Premium
The Fly
Eagle Pharmaceuticals to present data from Phase III trial of amisulpride
7M ago
Eagle Pharmaceuticals Risks Nasdaq Delisting Over Filing Delays
Premium
Company Announcements
Eagle Pharmaceuticals Risks Nasdaq Delisting Over Filing Delays
8M ago
Eagle provides update on bendamustine intellectual property portfolio
PremiumThe FlyEagle provides update on bendamustine intellectual property portfolio
10M ago
SHAREHOLDER ALERT: Potential Recovery for Eagle Pharmaceuticals, Inc. (EGRX) Investors
Premium
Class Action
SHAREHOLDER ALERT: Potential Recovery for Eagle Pharmaceuticals, Inc. (EGRX) Investors
11M ago
SHAREHOLDER ALERT: Potential Recovery for Eagle Pharmaceuticals, Inc. (EGRX) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit
Premium
Class Action
SHAREHOLDER ALERT: Potential Recovery for Eagle Pharmaceuticals, Inc. (EGRX) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100